InvestorsHub Logo
Followers 4
Posts 1233
Boards Moderated 0
Alias Born 07/31/2014

Re: BelizeMe post# 130715

Tuesday, 08/03/2021 6:54:32 PM

Tuesday, August 03, 2021 6:54:32 PM

Post# of 140474
Thanks for sharing your thoughts Belize me. Food for thought. I’m not sure I agree but I also know that I don’t know what they are developing. My guess is it’s not for current Hugo. They didn’t have enough time to implement and gain FDA submission and approvals with current timeline and believe they will probably use some of the clinical trial data they have from other countries for FDA. Good points on the value or lack there of in having all the robots. That being said, it certainly helps to have all the robotic offerings that the market leader (intuitive) has as well as the complementary portfolio that a Medtronic has.

It may be that it allows them to kick the tires on Enos as you stated below. The development agreement calls for a prototype of some sort to be delivered by Titan though so what could that be for? My guess is that Medtronic wanted some other functionality incoporated into Enos or there could be something to Rocko contention that they are helping with some type of Endoluminal offering. Could it be something under development at Medtronic or perhaps from another private company that Medtronic is working with? The two things that don’t add up for me is medtronic being given access to Titans BOD meetings if it is just to acquire some IP via licensing for their own needs. The other thing that is very odd is Sachin Sankholar going to Medtronic during this partnership. How can they be stealing Titans talent. No non compete? Wouldn’t this muddy the waters if they were going to run with some licensed IP from Titan without a deeper relationship?